Regulatory compliance – Page 37

Hybrid paper-electronic workflows uncontrolled during inspection walkthrough – CAPA and revalidation strategy

Addressing Uncontrolled Hybrid Paper-Electronic Workflows During Inspection Walkthroughs In recent regulatory inspections, hybrid paper-electronic workflows have become a significant area of scrutiny. When not managed correctly, these workflows can lead…

Poor QMS metrics during management review – building an inspection-resilient QMS

Tackling Poor QMS Metrics During Management Review: A Playbook for an Inspection-Resilient System Pharmaceutical organizations often face the challenge of poor quality management system (QMS) metrics during internal management reviews.…

Record retention failures during inspection walkthrough – 21 CFR Part 11 compliance gaps

Managing Record Retention Challenges During FDA/EMA/MHRA Inspections In today’s regulatory landscape, adherence to record retention requirements is non-negotiable, particularly under 21 CFR Part 11. Failures in maintaining accurate records can…

Ineffective deviation management during integration of new sites – building an inspection-resilient QMS

Ineffective Deviation Management During New Site Integrations: Building a Resilient QMS Transitioning new manufacturing sites into an existing Quality Management System (QMS) often uncovers hidden inefficiencies, particularly in deviation management.…

Record retention failures during inspection walkthrough – CAPA and revalidation strategy

Addressing Record Retention Failures During Inspection Walkthroughs: A Comprehensive CAPA and Revalidation Playbook In the highly regulated pharmaceutical environment, the integrity of record retention is pivotal for compliance during inspections.…

CAPA system overloaded during management review – metrics inspectors question

Managing Overload in CAPA Systems During Management Reviews In today’s highly regulated pharmaceutical environment, quality management systems (QMS) must be agile yet robust, particularly during management review periods. An overloaded…

Record retention failures during validation lifecycle – 21 CFR Part 11 compliance gaps

Addressing Record Retention Failures in the Validation Lifecycle for Compliance In pharmaceutical manufacturing, ensuring robust compliance with regulatory frameworks is critical. Record retention failures are a significant concern during the…

Audit findings repeat during management review – QMS maturity gap analysis

Addressing Recurring Audit Findings in Quality Management Reviews: A Practical Playbook Recurring audit findings during management reviews can indicate deeper systemic issues within a Quality Management System (QMS). As professionals…

Electronic signatures misused during system operation – risk-based ERES remediation

“`html Addressing Misuse of Electronic Signatures in System Operations: A Risk-Based Remediation Playbook The increasing reliance on electronic records and electronic signatures (ERES) in the pharmaceutical industry brings significant regulatory…

CAPA system overloaded during inspection readiness – building an inspection-resilient QMS

Creating a Resilient CAPA System for Inspection Readiness in Pharmaceutical Quality Management Pharmaceutical professionals know the challenges of maintaining an effective Corrective and Preventive Action (CAPA) system, particularly when facing…

Hybrid paper-electronic workflows uncontrolled during system operation – inspection evidence requirements

Managing Uncontrolled Hybrid Paper-Electronic Workflows in Pharmaceutical Operations In today’s pharmaceutical landscape, integrating hybrid paper-electronic workflows has become a necessity. However, uncontrolled workflows during system operation can lead to significant…

Change management weak during QMS redesign – CAPA governance model

Effective Strategies for Strengthening Change Management During QMS Redesign The pharmaceutical industry is undoubtedly intricate, with regulatory bodies steadfastly enforcing stringent quality and compliance standards. During a Quality Management System…